IRadimed CorporationIRMDNASDAQ
LOADING
|||
| Metric | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 |
|---|---|---|---|---|---|
| Revenue Growth | +11.04% | +11.10% | +10.87% | +13.84% | +15.69% |
| Gross Profit Growth | +10.55% | +10.05% | +10.87% | +13.89% | +16.22% |
| EBITDA Growth | -1.78% | +21.88% | +13.09% | +35.93% | +28.31% |
| Operating Income Growth | -1.97% | +12.41% | +14.39% | +20.63% | +18.04% |
| Net Income Growth | -0.35% | +13.37% | +13.32% | +17.81% | +10.44% |
| EPS Growth | +0.00% | +13.89% | +12.12% | +15.38% | +9.60% |
| EPS Diluted Growth | +0.00% | +11.11% | +15.62% | +18.42% | +8.40% |
| Weighted Average Shares Growth | +0.53% | +0.50% | +0.41% | +0.40% | +0.40% |
| Weighted Average Shares Diluted Growth | +0.33% | +0.35% | +0.59% | +0.57% | +0.64% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | +554.54% | +53.02% | +10.53% | +16.69% | -23.36% |
| Free Cash Flow Growth | +435.22% | -10.65% | -82.53% | -8.31% | +14.58% |
| Receivables Growth | -18.92% | -13.64% | -2.46% | -8.63% | +33.71% |
| Inventory Growth | -3.57% | -18.87% | -16.86% | -7.22% | +4.30% |
| Asset Growth | +7.83% | +6.69% | +15.58% | +18.34% | +21.72% |
| Book Value per Share Growth | +11.29% | +20.95% | +17.82% | +17.90% | +17.41% |
| Debt Growth | -87.70% | -92.43% | -96.94% | -100.00% | -100.00% |
| R&D Expense Growth | +41.30% | -12.37% | -23.97% | +9.52% | +5.46% |
| SG&A Expenses Growth | +19.81% | +10.36% | +12.39% | +9.34% | +15.75% |